Skip to main content

Optimal sampling times in population pharmacokinetic studies

Buy Article:

$43.00 plus tax (Refund Policy)

We propose a simulation-based approach to decision theoretic Bayesian optimal design. The underlying probability model is a population pharmacokinetic model which allows for correlated responses (drug concentrations) and patient-to-patient heterogeneity. We consider the problem of choosing sampling times for the anticancer agent paclitaxel, using criteria related to the total area under the curve, the time above a critical threshold and the sampling cost.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Clinical trial; Limited sampling strategies; Longitudinal data; Markov chain Monte Carlo methods; Optimal design; Population model

Document Type: Original Article

Affiliations: 1: University of Chicago, USA, 2: Duke University, Durham, USA

Publication date: 2001-01-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more